A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2018
At a glance
- Drugs Durvalumab (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 04 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Sep 2017 Trial design presented at the 42nd European Society for Medical Oncology Congress
- 25 Apr 2017 Status changed from not yet recruiting to recruiting.